Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Mil Med Res ; 8(1): 19, 2021 03 09.
Article in English | MEDLINE | ID: mdl-33750466

ABSTRACT

BACKGROUND: Invasive Trichosporon asahii (T. asahii) infection frequently occurs with a high mortality in immunodeficient hosts, but the pathogenesis of T. asahii infection remains elusive. Circular RNAs (circRNAs) are a type of endogenous noncoding RNA that participate in various disease processes. However, the mechanism of circRNAs in T. asahii infection remains completely unknown. METHODS: RNA sequencing (RNA-seq) was performed to analyze the expression profiles of circRNAs, microRNAs (miRNAs), and mRNAs in THP-1 cells infected with T. asahii or uninfected samples. Some of the RNA-seq results were verified by RT-qPCR. Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were used to analyze the differentially expressed mRNAs. A circRNA-miRNA-mRNA network was constructed and verified by dual-luciferase reporter assay and overexpression experiments. RESULTS: A total of 46 circRNAs, 412 mRNAs and 47 miRNAs were differentially expressed at 12 h after T. asahii infection. GO and KEGG analyses showed that the differentially expressed mRNAs were primarily linked to the leukocyte migration involved in the inflammatory response, the Toll-like receptor signaling pathway, and the TNF signaling pathway. A competing endogenous RNA (ceRNA) network was constructed with 5 differentially expressed circRNAs, 5 differentially expressed miRNAs and 42 differentially expressed mRNAs. Among them, hsa_circ_0065336 was found to indirectly regulate PTPN11 expression by sponging miR-505-3p. CONCLUSIONS: These data revealed a comprehensive circRNA-associated ceRNA network during T. asahii infection, thus providing new insights into the pathogenesis of the T. asahii-host interactions.


Subject(s)
Basidiomycota/drug effects , MicroRNAs/pharmacology , RNA, Circular/pharmacology , RNA, Messenger/pharmacology , Trichosporonosis/therapy , Basidiomycota/pathogenicity , Humans , MicroRNAs/therapeutic use , RNA, Circular/therapeutic use , RNA, Messenger/therapeutic use , Signal Transduction/drug effects
2.
Article in English | MEDLINE | ID: mdl-34192088

ABSTRACT

The 2019 novel coronavirus infection has brought a great challenge in prevention and control of the national epidemic of coronavirus disease 2019 (COVID-19) in China. During the fight against the epidemic of COVID-19, properly carrying out pre-examination and triage for patients with skin lesions and fever has been a practical problem encountered in hospitals for skin diseases as well as clinics of dermatology in general hospitals. Considering that certain skin diseases may have symptom of fever, and some of the carriers of 2019 novel coronavirus and patients with COVID-19 at their early stage may do not present any symptoms of COVID-19, to properly deal with the visitors to clinics of dermatology, the Chinese Society of Dermatology organized experts to formulate the principles and procedures for pre-examination and triage of visitors to clinics of dermatology during the epidemic of COVID-19.

3.
Asian Pac J Trop Med ; 10(1): 52-56, 2017 Jan.
Article in English | MEDLINE | ID: mdl-28107865

ABSTRACT

OBJECTIVE: To investigate the therapeutic potential of adipose-derived stem cells (ADSCs) for limited cutaneous scleroderma (LS) in mouse models. METHODS: ADSCs were isolated from pathogen-free female C57BL/6 mice and LS was induced in wild type (WT) C57BL/6 mice via daily injection of bleomycin (0.1 mL × 300 µg/mL) for 4 weeks; then the ADSCs were subcutaneously injected into the dorsal area in the model treatment group, and 100 µL of phosphate-buffered saline (PBS) solution was injected into the same site in the model control group. Green fluorescent protein (GFP) was used to track the cells using an in vivo imaging system on days 7, 14, 21, and 28 after transplantation. All mice were sacrificed and histologic analyses were performed after 4 weeks, and the skin thickness, collagen deposition and the total content of hydroxyproline were evaluated. Additionally, immunohistochemistry were performed to compare the tissue expression and distribution of TGF-ß1 and VEGF between the ADSCs treatment group and the treatment control group. RESULTS: WT C57BL/6 LS mouse model were successfully established and GFP in vivo fluorescence imaging showed that the translated ADSCs survived at the local for at least 4 weeks. Compared with the control group, the ADSCs treatment group significantly attenuated bleomycin-induced dermal fibrosis, reduced the skin thickness and the total content of hydroxyproline (P < 0.05). The ADSCs treatment group displayed significantly lower levels of TGF-ß1 and higher levels of VEGF than the control group (P < 0.05). CONCLUSIONS: ADSCs may provide a feasible and practical treatment for autoimmune diseases such as LS and ameliorate dermal fibrosis.

4.
Transplantation ; 100(4): 763-71, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26569069

ABSTRACT

BACKGROUND: Immune responses are somewhat suppressed in immune privileged sites, including the testes, which provide a preexisting opportunity to prolong allograft survival. Previous studies have shown that intratesticular islet allografts enjoy extended survival even without any immunosuppression. However, it is unknown if testicular immune privilege can be exploited to prolong the survival of a solid allograft, including the skin, because it is impractical to implant a solid tissue in human testes. METHODS: To immunize recipient mice, splenocytes from BALB/c mice were injected into the testis of C57BL/6 recipients 1 week before skin transplantation. CD8 + CD122+ and CD4 + FoxP3+ regulatory T [Treg] cells were quantified by fluorescence-activated cell sorting. RESULTS: Although donor-antigen inoculation alone did not delay skin allograft rejection, it significantly extended the allograft survival when combined with CD40/CD40L or B7/CD28 costimulatory blockade and further induced long-term skin allograft acceptance when both costimulatory pathways were blocked. Similarly, donor-antigen inoculation suppressed alloreactive T cell proliferation in draining lymph nodes of skin recipients in the presence of the same costimulatory blockade. Interestingly, donor-antigen inoculation via intratesticular injection increased CD8 + CD122+, but not CD4 + FoxP3+, Treg numbers after transplantation. However, both CD8 + CD122+ and CD4 + CD25+ Treg cells induced by donor-antigen inoculation and the costimulatory blockade were more potent in suppression than that induced without the inoculation. Depletion of CD8+ or CD25+ T cells largely abrogated long-term skin allograft survival induced by donor-antigen inoculation and the costimulatory blockade. CONCLUSIONS: Intratesticular inoculation with donor antigens promotes long-term skin allograft survival induced by conventional costimulatory blockade via the induction of both CD8 + CD122+ and CD4 + CD25+ Treg cells.


Subject(s)
CD8-Positive T-Lymphocytes/drug effects , Graft Survival/drug effects , Immune Tolerance/drug effects , Immunization/methods , Immunosuppressive Agents/pharmacology , Interleukin-2 Receptor alpha Subunit/immunology , Interleukin-2 Receptor beta Subunit/immunology , Isoantigens/immunology , Skin Transplantation , Skin/drug effects , Spleen/transplantation , T-Lymphocytes, Regulatory/drug effects , Abatacept/pharmacology , Allografts , Animals , CD40 Ligand/antagonists & inhibitors , CD40 Ligand/immunology , CD40 Ligand/metabolism , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , CTLA-4 Antigen/antagonists & inhibitors , CTLA-4 Antigen/immunology , CTLA-4 Antigen/metabolism , Cells, Cultured , Interleukin-2 Receptor alpha Subunit/metabolism , Interleukin-2 Receptor beta Subunit/metabolism , Isoantigens/metabolism , Lymphocyte Activation/drug effects , Male , Mice, Inbred BALB C , Mice, Inbred C57BL , Phenotype , Signal Transduction/drug effects , Skin/immunology , Skin/metabolism , Skin/pathology , Spleen/cytology , Spleen/immunology , Spleen/metabolism , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/metabolism , Time Factors
5.
J Microbiol Immunol Infect ; 49(2): 182-8, 2016 Apr.
Article in English | MEDLINE | ID: mdl-24877597

ABSTRACT

BACKGROUND/PURPOSE: Silver nanoparticles are receiving increasing attention in biomedical applications. This study aims at evaluating the antifungal properties of silver nanoparticles against the pathogenic fungus Trichosporon asahii. METHODS: The growth of T. asahii on potato dextrose agar medium containing different concentrations of silver nanoparticles was examined and the antifungal effect was evaluated using minimum inhibitory concentration. Scanning and transmission electron microscopy were also used to investigate the antifungal effect of silver nanoparticles on T. asahii. RESULTS: Silver nanoparticles had a significant inhibitory effect on the growth of T. asahii. The minimum inhibitory concentration of silver nanoparticles against T. asahii was 0.5 µg/mL, which was lower than amphotericin B, 5-flucytosine, caspofungin, terbinafine, fluconazole, and itraconazole and higher than voriconazole. Silver nanoparticles obviously damaged the cell wall, cell membrane, mitochondria, chromatin, and ribosome. CONCLUSION: Our results demonstrate that silver nanoparticles have good antifungal activity against T. asahii. Based on our electron microscopy observations, silver nanoparticles may inhibit the growth of T. asahii by permeating the fungal cell and damaging the cell wall and cellular components.


Subject(s)
Anti-Infective Agents/pharmacology , Nanoparticles , Silver/pharmacology , Trichosporon/drug effects , Cell Membrane/drug effects , Cell Membrane/physiology , Cell Wall/drug effects , Culture Media/chemistry , Microbial Sensitivity Tests , Microscopy, Electron, Scanning , Microscopy, Electron, Transmission , Permeability , Trichosporon/growth & development , Trichosporon/ultrastructure
6.
Exp Ther Med ; 10(4): 1528-1532, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26622519

ABSTRACT

Melanogenesis is a physiological process that results in the synthesis of melanin pigments, which serve a crucial function in hyperpigmentation. The aim of the present study was to determine the effects of angiotensin II (Ang II) on melanogenesis and to elucidate the molecular events of Ang II-induced melanogenesis. Experiments were performed on human melanocytes to elucidate the pigmenting effect of Ang II and the underlying mechanisms. The elements involved in melanogenesis, including melanin content, tyrosinase (TYR) activity, and microphthalmia-associated transcription factor (MITF) and TYR expression at the mRNA and protein levels were evaluated. Melanin content and TYR activity increased in response to Ang II treatment in a concentration-dependent manner. MITF and TYR mRNA and protein expression levels were increased significantly in response to Ang II in a concentration-dependent manner. The Ang II-induced increase in melanin synthesis was reduced significantly in response to co-treatment with Ro-32-0432, a protein kinase C (PKC) inhibitor, whereas co-treatment with H-89, a PKA inhibitor, did not attenuate the Ang II-induced increase in melanin levels. These results suggest that PKC is required for Ang II-induced pigmentation in human melanocytes and that the mechanism involves the PKC pathway and MITF upregulation.

7.
Int J Clin Exp Med ; 8(3): 3848-54, 2015.
Article in English | MEDLINE | ID: mdl-26064283

ABSTRACT

Systemic scleroderma is an autoimmune disease characterized by fibrotic changes in skin and other organs involving excessive collagen deposition. The transforming growth factor-ß (TGF-ß) signaling pathway plays a key role in the fibrotic process in systemic scleroderma (SSc). Astragalus polysaccharides (APS) isolated from one of the Chinese herbs, Astragalus mongholicus, are known to have a variety of immunomodulatory activities. The present study aimed to investigate the effect of APS on TGF-ß signaling and its potential mechanism using a murine model of bleomycin-induced scleroderma. Scleroderma was induced in C3H/He N mice by subcutaneous bleomycin injections daily for 21 days. Skin samples were obtained 7, 14, and 21 days and TGF-ß1, Smad2, Smad3 mRNA expression was observed by real time PCR. The hydroxyproline content which consistent with the collagen content in skin samples from the BLM-injected group was significantly higher than the PBS group, and corresponded with dermal thickening at the injection site. In contrast, mice treated with APS after initiating BLM injection showed obviously lesser collagen content. Increased TGF-ß1, Smad2, Smad3 mRNA expression were also observed in the BLM group. TGF-ß1, Smad2, Smad3 expression was significantly lesser for the APS group than for the BLM group. In contrast, TGF-ß1 mRNA expression was remarkably inhibited by APS. These results suggest that APS treatment may inhibit TGF-ß1 production, and thus could be a potential drug for managing fibrotic disorders such as SSc.

8.
Mol Med Rep ; 12(1): 651-6, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25760379

ABSTRACT

Angiotensin II (AngII) is a hormone with long-established cardiovascular actions. Previous studies have revealed an additional role for AngII in the regulation of cutaneous wound healing. To evaluate the association between AngII and abnormal pigmentation of cutaneous wound healing, the present study used human melanocytes to investigate the effects of AngII on melanogenesis, and to elucidate the possible underlying mechanisms. Primary culture melanocytes were treated with AngII either alone or in combination with an AngII type 1 (AT1) receptor antagonist, losartan (LOS). The melanin content and tyrosinase activity were measured and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blotting were performed to assess the proteins involved in melanogenesis and the AT1 receptor. AngII regulated the mRNA expression of AT1 in the melanocytes. The melanin content and tyrosinase activity increased in response to treatment with AngII in a concentration­dependent manner. RT-qPCR and western blotting revealed that the AT1 receptor antagonist, LOS, eliminated this effect. These results provide a novel insight into the role of AngII and its associated signaling in melanogenesis.


Subject(s)
Angiotensin II/genetics , Carcinogenesis/genetics , Melanoma/genetics , Receptor, Angiotensin, Type 1/genetics , Angiotensin II/metabolism , Angiotensin II Type 1 Receptor Blockers/administration & dosage , Humans , Losartan/administration & dosage , Melanins/metabolism , Melanocytes/metabolism , Melanocytes/pathology , Melanoma/metabolism , Melanoma/pathology , Primary Cell Culture , Receptor, Angiotensin, Type 1/metabolism , Signal Transduction/genetics
9.
Tumour Biol ; 36(3): 1471-6, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25371069

ABSTRACT

Inhibition of histone deacetylase (HDAC) activity by HDAC inhibitors (HDACis) results in cancer cell growth inhibition, and HDACis have been revealed as potential anti-skin cancer agents. p21 is a cyclin-dependent kinase inhibitor and an essential regulator of growth inhibition. Recently, we reported that activating transcription factor 3 (ATF3) could significantly promote skin cancer cell growth. This study explored the relationship between ATF3 and HDACi-induced growth inhibition of epidermoid carcinoma cells. We found that trichostatin A (TSA) treatment inhibited cell growth in A431 epidermoid carcinoma cells in a dose-dependent manner. Simultaneously, p21 and ATF3 expression levels were upregulated and downregulated upon TSA stimulation, respectively. ATF3 overexpression promoted cell growth and downregulated p21 expression. In contrast, ATF3 depletion resulted in cell growth reduction and p21 transcriptional upregulation. More importantly, ATF3 overexpression partially antagonized TSA-induced growth inhibition and p21 activation. Collectively, these data demonstrate that ATF3 acts as an essential negative regulator of TSA-induced cell growth inhibition through interfering with TSA-induced p21 activation.


Subject(s)
Activating Transcription Factor 3/genetics , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/genetics , Cyclin-Dependent Kinase Inhibitor p21/genetics , Histone Deacetylase Inhibitors/pharmacology , Histone Deacetylases/metabolism , Activating Transcription Factor 3/metabolism , Antineoplastic Agents/pharmacology , Carcinoma, Squamous Cell/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Proliferation/genetics , Down-Regulation/drug effects , Histone Deacetylases/genetics , Humans , Hydroxamic Acids/pharmacology , Transcriptional Activation/drug effects , Up-Regulation/drug effects
10.
Arch Pharm (Weinheim) ; 347(9): 609-15, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24917246

ABSTRACT

Scleroderma (systemic sclerosis) is a connective tissue disease that affects various organ systems; the treatment of scleroderma is still difficult and remains a challenge to the clinician. Recently, kinase inhibitors have shown great potential against fibrotic diseases and, specifically, the transforming growth factor-ß receptor (TGF-ßR) was found as a new and promising target for scleroderma therapy. In the current study, we propose that the large pool of existing kinase inhibitors could be exploited for inhibiting the TGF-ßR to suppress scleroderma. In this respect, we developed a modeling protocol to systematically profile the inhibitory activities of 169 commercially available kinase inhibitors against the TGF-ßR, from which five promising candidates were selected and tested using a standard kinase assay protocol. Consequently, two molecular entities, namely the PKB inhibitor MK-2206 and the mTOR C1/C2 inhibitor AZD8055, showed high potency when bound to the TGF-ßR, with IC50 values of 97 and 86 nM, respectively, which are close to those of the recently developed TGF-ßR selective inhibitors SB525334 and LY2157299 (IC50 = 14.3 and 56 nM, respectively). We also performed atomistic molecular dynamics simulations and post-molecular mechanics/Poisson-Boltzmann surface area analyses to dissect the structural basis and energetic properties of intermolecular interactions between the TGF-ßR kinase domain and these potent compounds, highlighting intensive nonbonded networks across the tightly packed interface of non-cognate TGF-ßR-inhibitor complexes.


Subject(s)
Protein Kinase Inhibitors/pharmacology , Receptors, Transforming Growth Factor beta/antagonists & inhibitors , Scleroderma, Systemic/drug therapy , Heterocyclic Compounds, 3-Ring/chemistry , Heterocyclic Compounds, 3-Ring/pharmacology , Heterocyclic Compounds, 3-Ring/therapeutic use , Humans , Imidazoles/chemistry , Imidazoles/pharmacology , Imidazoles/therapeutic use , Molecular Docking Simulation , Molecular Dynamics Simulation , Molecular Structure , Molecular Targeted Therapy , Morpholines/chemistry , Morpholines/pharmacology , Morpholines/therapeutic use , Protein Binding , Protein Kinase Inhibitors/chemistry , Protein Kinase Inhibitors/therapeutic use , Pyrazoles/chemistry , Pyrazoles/pharmacology , Pyrazoles/therapeutic use , Quinolines/chemistry , Quinolines/pharmacology , Quinolines/therapeutic use , Quinoxalines/chemistry , Quinoxalines/pharmacology , Quinoxalines/therapeutic use , Scleroderma, Systemic/enzymology , Scleroderma, Systemic/metabolism
11.
Mycopathologia ; 177(1-2): 51-7, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24442359

ABSTRACT

Invasive fungal infections due to Aspergillus species have become a major cause of morbidity and mortality among immunocompromised patients. In order to determine the possible relationship between environmental contamination by Aspergillus and the occurrence of invasive aspergillosis, a 1-year prospective study was carried out in a tertiary hospital in China. Air, surface, and tap water sampling was performed twice monthly at the bone marrow transplant (BMT) department, intensive care unit (ICU), neurosurgery intensive care unit (NICU), and outdoors. Nose, pharynx, and sputum samples were collected from high-risk patients. Isolates of Aspergillus from the environment and patients were genotyped by random amplification of polymorphic DNA (RAPD) assay to investigate the origin of infection. Mean total Aspergillus count was 7.73, 8.94, 13.19, and 17.32 cfu/m(3) in the BMT department, ICU, NICU, and outdoors, respectively. RAPD analysis by R108 primer demonstrated that strains isolated from patients in NICU were identical to the environmental strain. Strains isolated from patients in ICU differed from the environmental strain. Aspergillus contamination was found in the BTM department, NICU, and ICU. Clinical and environmental strains from NICU had identical genotypes. These findings suggest that Aspergillus is found in the hospital environment including the air, surface, and tap water. The genotypes of Aspergillus were identical from patients and the environment, suggesting that clinical infection may originate from the hospital environment.


Subject(s)
Aspergillosis/diagnosis , Aspergillus/classification , Aspergillus/genetics , Intensive Care Units , Operating Rooms , Air Microbiology , Aspergillosis/microbiology , Aspergillus/isolation & purification , China , Cross Infection/epidemiology , DNA, Fungal/genetics , Environmental Exposure , Genotype , Infection Control , Molecular Typing , Mycological Typing Techniques , Prospective Studies , Random Amplified Polymorphic DNA Technique , Soil Microbiology , Water Microbiology
12.
Photodermatol Photoimmunol Photomed ; 30(5): 246-53, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24313686

ABSTRACT

BACKGROUND AND AIMS: Acne vulgaris is common in Asian populations. We compared three methods of phototherapy for the treatment of moderate to severe facial acne vulgaris in Chinese patients. METHODS: Patients were randomly assigned to receive photodynamic therapy (PDT), intense pulsed light (IPL) or blue-red light-emitting diode (LED) phototherapy to the right side of the face until the inflammatory lesion count reduced by ≥ 90%. Patients were examined at 1 and 3 months after the final treatment. RESULTS: We enrolled 150 patients (92 males; mean age, 28 years). At 1 month, ≥90% clearance or moderate improvement occurred in 46/50 (92%), 29/50 (58%) and 22/50 (44%) patients in the PDT, IPL and LED groups, respectively (mean number of sessions required, PDT: 3 ± 1.52; IPL: 6 ± 2.15; LED: 9 ± 3.34). Forty-six (92%) patients experienced mild to moderate pain, erythema and edema after PDT, which resolved within 5-7 days. Slight erythema and stinging were reported immediately after IPL and LED, resolving within 2 h. After 3 months, minimal papules and pustules were observed in 4 patients in the PDT group, 7 in the IPL group and 12 in the LED group, but no nodular pustules recurred. CONCLUSIONS: Phototherapy is efficacious for moderate to severe facial acne vulgaris.


Subject(s)
Acne Vulgaris/therapy , Phototherapy/methods , Adolescent , Adult , Female , Humans , Male , Young Adult
13.
Chin Med J (Engl) ; 126(2): 361-8, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23324290

ABSTRACT

OBJECTIVE: To summarize the recent findings on the epidemiology of medically important, opportunistic invasive fungal infections (IFIs) in China and discuss the relevant social, economical reasons and medical factors. DATA SOURCES: We performed a comprehensive search of both English and Chinese literatures of opportunistic IFIs from China up to April 2012. STUDY SELECTION: Relevant literatures involving researches and cases/case series were identified, retrieved and reviewed. RESULTS: The incidence of opportunistic IFIs in China was steadily increasing. The incidence and mortality of IFIs were different in patients with various underlying conditions/diseases, from 4.12% to 41.18% and 9.8% to 60.0%, respectively. Candida species, Aspergillus species and Cryptococcus neoformans species complex were the most frequent isolated pathogens. Other uncommon opportunistic IFIs were also been reported, including trichosporonosis, mucormycosis, hyalohyphomycosis (hyaline hyphomycetes) and phaeohyphomycosis (dematiaceous hyphomycetes). Reports of Chinese patients differed from those of many other countries as there were a higher number of patients without identifiable underlying diseases/conditions. CONCLUSIONS: Because of the rapid economic development, changing population structure and a growing number of immunocompromised hosts with risk factors, today opportunistic IFIs in China have a significant impact on public health, associated with high morbidity/mortality and higher care costs. Now information related to the epidemiology of opportunistic IFIs in China is still sparse, so we need more organized groups of clinical scientists performing related researches to help the clinicians to obtain more accurate epidemiological characteristics.


Subject(s)
Mycoses/epidemiology , Opportunistic Infections/epidemiology , China/epidemiology , Humans , Incidence , Mycoses/mortality , Opportunistic Infections/mortality
14.
Clin Infect Dis ; 56(7): 993-5, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23243187

ABSTRACT

We herein report a case of slowly progressive cutaneous, rhinofacial, and pulmonary mucormycosis caused by Mucor irregularis in an immunocompetent woman who was successfully managed by combined surgical debridement and antifungal therapy. Slow progression, pulmonary involvement, occurrence in an immunocompetent patient, and good prognosis are unusual features of our case.


Subject(s)
Facial Dermatoses/pathology , Lung Diseases, Fungal/pathology , Mucor/isolation & purification , Mucormycosis/diagnosis , Mucormycosis/pathology , Nose Diseases/pathology , Adult , Antifungal Agents/administration & dosage , DNA, Fungal/chemistry , DNA, Fungal/genetics , Debridement , Facial Dermatoses/complications , Facial Dermatoses/drug therapy , Facial Dermatoses/surgery , Female , Humans , Lung Diseases, Fungal/complications , Lung Diseases, Fungal/drug therapy , Molecular Sequence Data , Mucormycosis/drug therapy , Mucormycosis/surgery , Nose Diseases/complications , Nose Diseases/drug therapy , Nose Diseases/surgery , Sequence Analysis, DNA , Treatment Outcome
15.
Asian Pac J Cancer Prev ; 14(12): 7439-44, 2013.
Article in English | MEDLINE | ID: mdl-24460316

ABSTRACT

AIM: ATF3, a member of the ATF/CREB family of transcription factors, has been found to be selectively induced by calcineurin/NFAT inhibition and to enhance keratinocyte tumor formation, although the precise role of ATF3 in human skin cancer and possible mechanisms remain unknown. METHODS: In this study, clinical analysis of 30 skin cancer patients and 30 normal donors revealed that ATF3 was accumulated in skin cancer tissues. Functional assays demonstrated that ATF3 significantly promoted skin cancer cell proliferation. RESULTS: Mechanically, ATF3 activated Stat3 phosphorylation in skin cancer cell through regulation of p53 expression. Moreover, the promotion effect of ATF3 on skin cancer cell proliferation was dependent on the p53-Stat3 signaling cascade. CONCLUSION: Together, the results indicate that ATF3 might promote skin cancer cell proliferation and enhance skin keratinocyte tumor development through inhibiting p53 expression and then activating Stat3 phosphorylation.


Subject(s)
Activating Transcription Factor 3/metabolism , Carcinoma, Squamous Cell/pathology , Cell Proliferation , STAT3 Transcription Factor/metabolism , Skin Neoplasms/pathology , Skin/metabolism , Tumor Suppressor Protein p53/metabolism , Activating Transcription Factor 3/genetics , Blotting, Western , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/metabolism , Cells, Cultured , Humans , Immunoenzyme Techniques , Phosphorylation , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , STAT3 Transcription Factor/genetics , Skin Neoplasms/genetics , Skin Neoplasms/metabolism , Tumor Suppressor Protein p53/genetics
16.
Eukaryot Cell ; 11(12): 1586-7, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23193141

ABSTRACT

This is the first report of the genome sequence of Trichosporon asahii environmental strain CBS 8904, which was isolated from maize cobs. Comparison of the genome sequence with that of clinical strain CBS 2479 revealed that they have >99% chromosomal and mitochondrial sequence identity, yet CBS 8904 has 368 specific genes. Analysis of clusters of orthologous groups predicted that 3,307 genes belong to 23 functional categories and 703 genes were predicted to have a general function.


Subject(s)
Genome, Fungal , Trichosporon/genetics , Base Sequence , Databases, Genetic , Molecular Sequence Data
17.
Eukaryot Cell ; 11(11): 1415-6, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23104369

ABSTRACT

Trichosporon asahii is one of the important opportunistic pathogenic fungi. Here, we first report the draft nuclear chromosome genome sequence and mitochondrial genome sequence of T. asahii CBS 2479, which is a standard strain of T. asahii that was isolated from a progressive psoriatic lesion. COG analysis predicted that 3,131 genes were assigned to 23 functional categories and that 628 genes were predicted to have a general function.


Subject(s)
Chromosomes, Fungal/genetics , Genome, Fungal , Genome, Mitochondrial , Trichosporon/genetics , Base Sequence , Cell Nucleus/genetics , DNA, Mitochondrial/genetics , Molecular Sequence Data , Open Reading Frames , Sequence Alignment
18.
Chin Med J (Engl) ; 125(14): 2632-5, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22882952

ABSTRACT

Trichosporon species now ranks as the second most common cause of disseminated yeast infections with a high mortality rate. Breakthrough trichosporonosis in patients receiving echinocandins therapy is being recognized recently. We present a case of breakthrough trichosporonosis with acute viral myocarditis while receiving caspofungin therapy. Trichosporon infection should be considered in patients, who have risk factors for invasive fungal infection and develop unexplained clinical manifestations of infection despite treatment with echinocandins.


Subject(s)
Antifungal Agents/therapeutic use , Echinocandins/therapeutic use , Trichosporonosis/drug therapy , Adult , Caspofungin , Female , Humans , Lipopeptides , Treatment Outcome , Trichosporonosis/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...